Jeffrey Siegel MD

Jeffrey Siegel, M.D. is Senior Group Medical Director in Product Development Immunology at Genentech / Roche. His areas of responsibility include Rheumatology, rituximab, personalized health care and Rare Diseases/Orphan Indications. He received his medical degree from Yale University School of Medicine, internship and residency training at the University Hospitals of Cleveland, clinical fellowship training in Rheumatology at University Hospitals of Cleveland and basic science research training at the NIH in Immunology and signal transduction. After fellowship he joined the Naval Medical Research Institute for 5 years where he served as Branch Head, Signal Transduction. He then joined the FDA and was there for 14 years, serving as Supervisory Medical Officer, Clinical Team Leader in Rheumatology.